Q4 2024 Management View CEO Sheri Dodd reported strong Q4 financial performance, with total revenue of $85.6 million, marking a 10.2% year-over-year increase. Lymphedema business line sales rose 11% ...
Critics warn of potential corruption and unchecked political influence in managing state-owned assets via new sovereign ...